Sciele Pharma Will Market Clonicel Under Addrenex Deal
Addrenex will submit NDA for sustained-release clonidine for hypertension later this year, followed by application for ADHD.
Addrenex will submit NDA for sustained-release clonidine for hypertension later this year, followed by application for ADHD.